Clinical continuity. Technical evidence.Atlant Security
Hospital/PentestBY ATLANT SECURITY

HOSPITAL PENETRATION TESTING

EHR, PACS & clinical integration testing

Test the trust relationships around clinical applications and their supporting services.

Discuss your requirements

The boundary worth testing

User interfaces, interface engines and archive services may apply different permissions. The scope must explain whether the test covers the application, infrastructure, an integration or all three.

An administrative support session may cross from a vendor access broker into recovery management. A working backup may still depend on an unavailable identity provider before a restored clinical application can be used. We connect these technical details to an agreed service boundary.

What the scope can include

  • Synthetic patient and clinician access boundaries
  • Clinical document and referral workflow authorisation
  • Archive access and approved imaging integration endpoints
  • Interface-engine credentials and deployment artefacts

The final proposal identifies the specific applications, accounts, environments and interfaces included. It also states which prerequisites your team or a supplier must provide.

What useful proof looks like

Trace one seeded workflow across the relevant systems and compare expected access decisions. Capture the synthetic record identifier, requesting principal and downstream audit entry without collecting patient records.

Preserve UTC time, asset identifier, requesting principal, expected decision and observed response. State-changing tests need confirmation from the resulting object or a trusted audit record. Denied operations and effective controls remain part of the outcome.

Safety and assessment limits

The engagement does not assess clinical efficacy, medical-device conformity or vendor product certification. No alteration of a real treatment order is implied or authorised.

Agree stop conditions with clinical operations and biomedical engineering. Exclude treatment changes and active interrogation of sensitive devices unless specifically approved. Use a canary clinical workflow, controlled rates and a named on-call decision maker for every test window.

Close the loop

Connect each weakness to a named owner, immediate safeguard and durable correction. Define positive and negative retest cases so the change restores the intended boundary while preserving legitimate use. Open items retain their dependencies and deadlines.

Preview the sector sample report to see the evidence and treatment-plan format.

LET’S START A CONVERSATION

Define the scope.
Take the next step.

Your systems, operating constraints and security objectives. A clear starting point for the test.

Discuss your pentest